ProfileGDS4459 / ENSG00000169118
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 35% 43% 47% 29% 41% 50% 48% 48% 48% 40% 49% 51% 39% 42% 40% 22% 38% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.9335
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.1943
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.2747
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.8129
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.0741
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.3950
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.3448
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.2948
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.3148
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.0240
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.2649
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.451
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.9839
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.1742
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.9540
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.4822
GSM623480group B, liver allograft wedge biopsie placebo treatment 7438